The MGC Pharmaceuticals (ASX:MXC) share price is on a roll today. Here's why

The MGC Pharmaceuticals (ASX: MXC) share price is up 3.4% after the company shared news of a $1 million order.

| More on:
Three pills with faces showing sad to happy, indicating a rising share price for an ASX pharmaceutical company

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MGC Pharmaceuticals Ltd (ASX: MXC) share price is having a great day as the company shared news of a $1 million order.

At its intraday high, the MGC Pharmaceuticals share price was 6.7% higher than yesterday's close, but it's since retreated.

The company's share price is trading at 6.1 cents, a 3.39% gain, at the time of writing.

Let's take a closer look at the latest news from the phytocannabinoid- and plant-focused pharmaceutical company.

Million-dollar baby

MGC Pharmaceuticals' newest purchase order comes from a European producer and distributor, Swiss PharmaCan AG.

Swiss PharmaCan has ordered around €640,000 ($995,000) worth of the company's ArtemiC Rescue, a food supplement that contains 4 plant-based ingredients ­– artemisinin, curcumin, boswellia serrata, and vitamin C.

This is its second order for ArtemiC Rescue after the first helped boost MGC Pharmaceuticals' quarter-on-quarter growth to a record high.

MGC Pharmaceutical says it has the ability to produce commercial-scale batches of ArtemiC Rescue at its Slovenian facility. 

The company has an agreement with Swiss PharmaCan, under which the European company must order at least 40,000 united of ArtemiC Rescue per quarter. The order announced today has seen it meet its quota for the current quarter.

Commentary from management

MGC Pharmaceuticals' co-founder and managing director Roby Zomer commented on the purchase order, saying:

Receiving a second order on such a large scale from Swiss PharmaCan demonstrates the increasing demand for our product ArtemiC Rescue, and its associated benefits.

Our team in Slovenia has been working tirelessly to ramp up production to ensure rapid deployment of this order, and any subsequent orders that may be received.

MGC Pharmaceuticals share price snapshot

The MGC Pharmaceuticals share price is going gangbusters this year, up 205% year to date with today's gains included. It's also up 103% over the last 12 months.

The company has a market capitalisation of around $134 million, with approximately 2.2 billion shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Man looking happy and excited as he looks at his mobile phone.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on big news

This stock is getting a lot of attention from investors on Wednesday. But why?

Read more »

Four smiling young medics with arms crossed stand outside a hospital.
Healthcare Shares

How much further upside is there for Mesoblast shares after soaring 23% in a month?

Could FDA approval send this healthcare stock towards further gains?

Read more »

woman in lab coat conducting testing representing biotech
Healthcare Shares

Is this soaring ASX 200 healthcare share just getting started?

If its lead therapy gets US approval, the stock can continue to climb.

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Own CSL shares? Here are the key dates for 2026

It's been a bad year for CSL shares. What's ahead in 2026?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Healthcare Shares

Is Sigma Healthcare share a healthy buy, after hitting new lows?

The Chemist Warehouse merger and ageing population might boost this stock's appeal.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Telix shares fall despite 'significant milestone'

Let's see what the biotech has announced on Monday.

Read more »